Stay updated on Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-04-30T13:55:54.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The webpage has been updated to include new clinical trial identifiers and drug information, specifically regarding the combination of pembrolizumab and tazemetostat for treating advanced urothelial carcinoma. Additionally, the trial's revision date has been updated to reflect the latest version.
    Difference
    57%
    Check dated 2025-04-16T02:07:43.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-08T23:36:53.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated with new dates and a revised version of the study documents provided by the National Cancer Institute, indicating a change in the available information.
    Difference
    0.5%
    Check dated 2025-04-01T18:27:23.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The page has updated the hospital name to Mercy Hospital Pittsburg and removed the previous hospital name, Ascension Via Christi - Pittsburg. Additionally, several dates have been changed, indicating a shift in scheduling or availability.
    Difference
    0.5%
    Check dated 2025-03-25T13:08:49.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.7%
    Check dated 2025-03-03T21:54:10.000Z thumbnail image

Stay in the know with updates to Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page.